摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-氨基-6-氯喹啉-4-醇 | 64319-84-2

中文名称
2-氨基-6-氯喹啉-4-醇
中文别名
——
英文名称
2-amino-6-chloro-quinolin-4-ol
英文别名
2-Amino-6-chlor-4-hydroxy-chinolin;2-Amino-6-chlor-chinolin-4-ol;2-Amino-6-chloro-4-hydroxyquinoline;2-Amino-6-chloroquinolin-4-OL;2-amino-6-chloro-1H-quinolin-4-one
2-氨基-6-氯喹啉-4-醇化学式
CAS
64319-84-2
化学式
C9H7ClN2O
mdl
MFCD08234779
分子量
194.62
InChiKey
UULPLGYNAXFLEP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    13
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    55.1
  • 氢给体数:
    2
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2933499090

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-氨基-6-氯喹啉-4-醇三溴化磷三溴氧磷sodium hydroxide 作用下, 以 为溶剂, 反应 16.0h, 以98%的产率得到4-bromo-6-chloro-quinolin-2-ylamine
    参考文献:
    名称:
    QUINOLINES
    摘要:
    本发明涉及式I的2-氨基喹啉,其中R1、R2和R3如规范中定义的,作为5-HT5A受体拮抗剂,它们的制造、含有它们的药物组合物以及它们用于治疗中枢神经系统疾病的用途。
    公开号:
    US20090088451A1
  • 作为产物:
    描述:
    5-氯靛红酸酐 以86%的产率得到
    参考文献:
    名称:
    KADIN S. B.; LAMPHERE C. H., SYNTHESIS , 1977, NO 7, 500-501
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • 2-Amino-3-cyano-4-hydroxyquinolines
    申请人:Pfizer Inc.
    公开号:US04175193A1
    公开(公告)日:1979-11-20
    The reaction of isatoic anhydrides with malononitrile in a reaction-inert solvent in the presence of a base to produce 2-amino-3-cyano-4-hydroxyquinolines and 2-amino-.alpha.,.alpha.-dicyanoacetophenones which are then hydrolyzed and decarboxylated under acid or base conditions to produce 2-amino-4-hydroxyquinolines, useful as intermediates for preparation of 1-oxo-1H-6-alkoxypyrimido[1,2-a]quinoline-2-carboxylic acids and esters of value as antiallergy agents.
    在反应惰性溶剂和碱的存在下,异烟酰亚胺与马隆腈反应,生成2-氨基-3-氰基-4-羟基喹啉和2-氨基-.alpha.,.alpha.-二氰基乙酰苯,然后在酸性或碱性条件下水解和脱羧,生成2-氨基-4-羟基喹啉,作为制备1-氧代-1H-6-烷氧基嘧啶并[1,2-a]喹啉-2-羧酸和酯的中间体,这些化合物对抗过敏有价值。
  • Process for making 2-amino-4-hydroxyquinolines
    申请人:Pfizer Inc.
    公开号:US04247699A1
    公开(公告)日:1981-01-27
    The reaction of isatoic anhydrides with malononitrile in a reaction-inert solvent in the presence of a base to produce 2-amino-3-cyano-4-hydroxy-quinolines and 2-amino-.alpha.,.alpha.-dicyanoacetophenones which are then hydrolyzed and decarboxylated under acid or base conditions to produce 2-amino-4-hydroxy-quinolines, useful as intermediates for preparation of 1-oxo-1H-6-alkoxy-pyrimido[1,2-a]quinoline-2-carboxylic acids and esters of value as antiallergy agents.
    在反应惰性溶剂存在碱的情况下,异吲哚酐与丙二腈发生反应,生成2-氨基-3-氰基-4-羟基喹啉和2-氨基-.alpha.,.alpha.-二氰基苯乙酮,然后在酸性或碱性条件下水解和脱羧,生成2-氨基-4-羟基喹啉,用作制备1-氧代-1H-6-烷氧基-嘧啶并[1,2-a]喹啉-2-羧酸和酯的中间体,这些化合物具有抗过敏作用。
  • Quinolines
    申请人:Kolczewski Sabine
    公开号:US08399674B2
    公开(公告)日:2013-03-19
    The present invention relates to 2-aminoquinolines of formula I wherein R1, R2 and R3 are as defined in the specification, as 5-HT5A receptor antagonists, their manufacture, pharmaceutical compositions containing them and their use for the treatment of CNS disorders.
    本发明涉及公式I中的2-氨基喹啉,其中R1、R2和R3如规范中所定义,作为5-HT5A受体拮抗剂,其制备方法,包含它们的制药组合物以及它们用于治疗中枢神经系统疾病的用途。
  • Design, synthesis and characterization of a novel class of coumarin-based inhibitors of inducible nitric oxide synthase
    作者:Sharon A. Jackson、Sukhveen Sahni、Lan Lee、Yongyi Luo、Thaddeus R. Nieduzak、Guyan Liang、Yulin Chiang、Nicola Collar、David Fink、Wei He、Abdelazize Laoui、Jean Merrill、Ray Boffey、Peter Crackett、Bryan Rees、Melanie Wong、Jean-Pierre Guilloteau、Magali Mathieu、Sam S. Rebello
    DOI:10.1016/j.bmc.2005.02.036
    日期:2005.4
    Inducible nitric oxide synthase (iNOS) has been implicated in various central and peripheral pathophysiological diseases. Our high throughput screening initially identified a weak inhibitor of iNOS, thiocoumarin 13. From this lead, a number of potent derivatives were prepared that demonstrate favorable potency, selectivity and kinetics. Compound 30 has an IC50 of 60 nM for mouse iNOS and 185-fold and 9-fold selectivity for bovine eNOS and rat nNOS, respectively. In cellular assays for iNOS, this compound has micromolar potency. Furthermore, two compounds (16 and 30) demonstrate a reasonable pharmacokinetic profile in rodents. The synthesis, SAR, and biological activity of this novel class of compounds is described.
  • Cyclic amidines. Part II. Derivatives of 2-amino-4-hydroxyquinoline
    作者:R. Hardman、M. W. Partridge
    DOI:10.1039/jr9540003878
    日期:——
查看更多